Hepatitis C: not so indolent in survivors of pediatric cancer?
Schwarz
Kathleen B
KB
Pediatric Liver Center, Division of Pediatric Gastroenterology and Nutrition, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. kschwarz@jhmi.edu
D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000032:analysis / Q000378:metabolism; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy / Q000235:genetics; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology*; D012333:RNA, Messenger / Q000187:drug effects / Q000235:genetics; D012254:Ribavirin / Q000627:therapeutic use; D055815:Young Adult
D000998:Antiviral Agents; D012333:RNA, Messenger; D012254:Ribavirin; D007372:Interferons; D000410:Alanine Transaminase